

Prof Laure Gossec
Professor Laure Gossec is Professor of Rheumatology in Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France. Professor Gossec has a half-time clinical position where she mainly sees patients with inflammatory arthritis, and a half-time teaching and research position.
Professor Gossec earned her medical degree and conducted her specialty training in rheumatology at Paris Descartes University, France, and earned her PhD in clinical epidemiology from Montpellier University, France. Professor Gossec’s clinical research focuses on particular outcomes research and epidemiological research, with a focus on outcome measures, prediction of outcome and targeted treatments, in psoriatic arthritis (PsA), rheumatoid arthritis (RA) and spondyloarthritis. Professor Gossec is particularly interested in the patient’s perspective and patient-centred research, and e-health and artificial intelligence for rheumatology research.
In 2023, Professor Gossec has coordinated work on quality of life in spondyloarthritis in several databases, she was the methodologist for a European Alliance of Associations of Rheumatology (EULAR) Task Force on patient involvement in research (led by Dr de Wit, Netherlands) and she co-led a EULAR Task Force with Professor Smolen (Austria) to produce an update of the EULAR recommendations for the management of PsA.
Professor Gossec is past Chair of the Epidemiology standing committee of EULAR and is a founding member and past Chair of the Emerging EULAR Network (EMEUNET). She is an Associate Editor for Joint Bone Spine.
Professor Gossec has authored more than 450 peer-reviewed manuscripts published in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Rheumatology and Arthritis Research and Therapy.
The speakers discuss the continued unmet needs of patients with inflammatory diseases of skin and joints in terms of treatment outcomes and health-related...
This session reviews the chronic inflammation and pathophysiology of HS, highlighting the association between patients with inflammatory arthritis and HS. The...
This session focuses on the pathobiological relationship between psoriasis and psoriatic arthritis (PsA), how transition from psoriasis to PsA occurs, as well as...
In this session, our speakers explore the inflammatory pathways in immune-mediated inflammatory disease in the context of the evolving treatment considerations...
Following a warm welcome by a senior UCB leader and our Summit Chairs, Plenary 1 examines how higher treatment targets can be met in patients with immune...
Dermatologists Dr. Álvaro González-Cantero, Dr. Annunziata Dattola and Dr. Nina Magnolo discuss how the materials on the Women and Psoriasis website can be used...